Trial Profile
Evaluation of viral efficacy and safety of a reduced dose of stavudine (d4t): The Phoenix Study
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Stavudine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms PHOENIX
- 04 Jul 2007 New trial record.